Envestnet Asset Management Inc Morpho Sys Ag Transaction History

Envestnet Asset Management Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$8.6 - $18.18 $94,256 - $199,252	-10,960 Reduced 36.98%	18,679 $338,000
Q4 2023 Feb 13, 2024	BUY	$4.55 - $9.9 $69,241 - $150,658	15,218 Added 105.53%	29,639 $293,000
Q3 2023 Nov 13, 2023	BUY	$6.72 - $8.6 $96,909 - $124,020	14,421 New	14,421 $96,000
Q2 2021 Aug 04, 2021	SELL	$18.95 - $23.95 $578,600 - $731,265	-30,533 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$21.56 - $30.66 $96,847 - $137,724	4,492 Added 17.25%	30,533 $666,000
Q4 2020 Feb 02, 2021	BUY	$24.81 - $30.33 $81,823 - $100,028	3,298 Added 14.5%	26,041 $738,000
Q3 2020 Oct 09, 2020	BUY	$30.28 - $35.72 $23,073 - $27,218	762 Added 3.47%	22,743 $714,000
Q2 2020 Jul 08, 2020	BUY	$24.08 - $33.35 $105,422 - $146,006	4,378 Added 24.87%	21,981 $696,000
Q1 2020 Apr 23, 2020	SELL	$18.86 - $37.36 $4,205 - $8,331	-223 Reduced 1.25%	17,603 $433,000
Q4 2019 Feb 11, 2020	BUY	$26.07 - $36.32 $45,205 - $62,978	1,734 Added 10.78%	17,826 $636,000
Q3 2019 Oct 17, 2019	SELL	$24.18 - $31.58 $39,050 - $51,001	-1,615 Reduced 9.12%	16,092 $442,000
Q2 2019 Aug 02, 2019	SELL	$23.24 - $26.76 $22,589 - $26,010	-972 Reduced 5.2%	17,707 $427,000
Q1 2019 May 10, 2019	SELL	$22.55 - $29.84 $88,283 - $116,823	-3,915 Reduced 17.33%	18,679 $424,000
Q4 2018 Feb 13, 2019	BUY	$21.96 - $31.02 $496,164 - $700,865	22,594 New	22,594 $572,000
Q3 2018 Nov 14, 2018	SELL	$26.64 - $35.66 $8,205 - $10,983	-308 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$25.15 - $30.6 $7,746 - $9,424	308 New	308 $9,000

1.84M

79.8K

688K

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.